Resources

Product Testing vs. Product Registration: The Difference

Product testing and product registration are different things that answer different questions. Testing is a laboratory activity: it verifies what a specific batch of a product actually contains. Registration is a regulatory process: an authority such as the Philippine FDA reviews evidence and authorizes a product for the market. A tested product is not necessarily a registered one, and a registered product still deserves batch-level testing.

In conversation, "has this product been checked?" collapses two very different processes into one. A supplier may answer "yes, it's tested" when the real question was about regulatory status, or wave a registration-related document when the question was about the batch in your refrigerator. The confusion is convenient for sellers and dangerous for patients. Operators need to hold the two apart.

What product testing is

Product testing is a laboratory examination of a product (ideally of the specific batch you hold) that measures defined quality attributes: identity, strength, purity, sterility where applicable, endotoxins, stability. It answers the question what is this, and does it match its claims? Testing is performed by laboratories, reported on certificates of analysis, and can be commissioned by anyone: a manufacturer, a distributor, or an operator verifying what it bought. Ourtesting checklist covers the full scope.

What product registration is

Product registration is an authorization granted by a regulatory authority (in the Philippines, the Food and Drug Administration) after a review of the evidence supporting a product's quality, safety, and intended use. Registration is a legal status, not a measurement. It answers the question is this product authorized for this market? It involves dossiers, review timelines, and regulatory judgment; no laboratory, however good, can issue it.

Why one cannot substitute for the other

The two processes are complementary because each has a blind spot the other covers.

Put simply: registration governs the product; testing verifies the batch. A market authorization does not freeze quality in place, and a passing assay does not create legal authorization. Both matter before patient access.

What this means for Philippine operators

For a clinic or wellness operator, the practical implications run in both directions. When evaluating a product, ask about its regulatory status explicitly and separately from its test results. Do not let a certificate of analysis stand in for an answer about registration, or vice versa. When sourcing, expect suppliers to speak precisely about both, and treat vagueness on either as a red flag.

Within Pepty's own framework, the distinction is structural.Independent testing is a verification gate; it operates alongside (never instead of) the regulatory requirements that apply to any product offered to patients. Where a product's regulatory pathway is unresolved, the responsible position is to say so plainly rather than let strong lab results blur the gap.

The questions to keep separate

When reviewing any product, write these as two lines, not one:

  1. What is this batch, and what did independent testing find in it?
  2. What is this product's regulatory status in the Philippines, and what documentation supports that?

If your supplier, your records, or your own checklist answers both with a single document, look again. The answer to one is never the answer to the other.

Common questions

If a product is registered abroad, is it authorized in the Philippines?

Not automatically. Regulatory authorizations are jurisdiction-specific. Foreign registration may be relevant evidence, but Philippine market authorization is a separate question governed by Philippine FDA processes.

Does Pepty's testing give a product regulatory status?

No. Testing, by Pepty or anyone, is verification of quality attributes. It confers no regulatory authorization, and responsible operators should treat any suggestion otherwise as a warning sign.

Which should a clinic check first?

Both, before patient access: they are parallel requirements, not sequential steps. Regulatory status determines whether the product may be offered at all; batch testing determines whether the specific units you received deserve the confidence the paperwork assumes.

Sources and references

  1. Philippine Food and Drug Administration (FDA): regulations and circulars on product registration of drug products.
  2. World Health Organization: guidelines on national drug regulatory authorities and quality assurance.
  3. Pepty: how independent testing works in practice. See /independent-testing.

The First 50

For the people who want to get this right.

Apply for the first Pepty workshop and learn what it takes to build a responsible peptide program in the Philippines.

Applications are reviewed for fit, readiness, and commitment to responsible care.